$FIGS
FIGS, Inc.

2021 Q4 Form 10-K Financial Statement

#000095017022003380 Filed on March 10, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $128.7M $419.6M $90.19M
YoY Change 42.69% 59.47%
Cost Of Revenue $38.70M $118.4M $26.13M
YoY Change 48.07% 62.4%
Gross Profit $90.00M $301.2M $64.06M
YoY Change 40.5% 58.35%
Gross Profit Margin 69.93% 71.79% 71.02%
Selling, General & Admin $73.57M $290.2M $51.29M
YoY Change 43.44% 119.41%
% of Gross Profit 81.74% 96.35% 80.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $403.0K $1.400M
YoY Change 55.56%
% of Gross Profit 0.45% 0.46%
Operating Expenses $73.57M $290.2M $51.29M
YoY Change 43.44% 119.41%
Operating Profit $16.43M $10.98M $12.77M
YoY Change 28.68% -81.04%
Interest Expense -$63.00K -$239.0K $8.000K
YoY Change -887.5% -275.74%
% of Operating Profit -0.38% -2.18% 0.06%
Other Income/Expense, Net -$60.00K $885.0K
YoY Change
Pretax Income $16.31M $9.859M $12.78M
YoY Change 27.64% -83.02%
Income Tax $3.715M $19.42M $653.0K
% Of Pretax Income 22.78% 196.93% 5.11%
Net Earnings $12.60M -$9.556M $12.13M
YoY Change 3.88% -119.2%
Net Earnings / Revenue 9.79% -2.28% 13.44%
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share $76.88K -$0.06 $75.72K
COMMON SHARES
Basic Shares Outstanding 159.2M
Diluted Shares Outstanding 159.2M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $195.4M $195.4M
YoY Change 236.08%
Cash & Equivalents $195.4M $195.4M $58.13M
Short-Term Investments
Other Short-Term Assets $9.456M $9.456M
YoY Change 41.88%
Inventory $86.07M $86.07M $49.74M
Prepaid Expenses $5.440M $1.406M
Receivables $1.653M $2.441M $5.780M
Other Receivables $788.0K $0.00
Total Short-Term Assets $293.3M $293.3M $120.3M
YoY Change 143.81% 143.81%
LONG-TERM ASSETS
Property, Plant & Equipment $7.613M $7.613M $6.529M
YoY Change 16.6% 16.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $560.0K $10.80M $506.0K
YoY Change 10.67% 53.99%
Total Long-Term Assets $18.41M $18.41M $13.54M
YoY Change 35.96% 35.96%
TOTAL ASSETS
Total Short-Term Assets $293.3M $293.3M $120.3M
Total Long-Term Assets $18.41M $18.41M $13.54M
Total Assets $311.8M $311.8M $133.9M
YoY Change 132.9% 132.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.60M $14.60M $11.97M
YoY Change 22.06% 22.06%
Accrued Expenses $24.68M $34.87M $6.682M
YoY Change 269.31% 149.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $62.39M $62.39M $32.52M
YoY Change 91.87% 91.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $243.0K $3.785M $0.00
YoY Change 3.44%
Total Long-Term Liabilities $243.0K $3.785M $0.00
YoY Change 3.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $62.39M $62.39M $32.52M
Total Long-Term Liabilities $243.0K $3.785M $0.00
Total Liabilities $66.18M $66.18M $36.18M
YoY Change 82.92% 82.92%
SHAREHOLDERS EQUITY
Retained Earnings $17.93M $27.49M
YoY Change -34.77%
Common Stock $227.6M $70.19M
YoY Change 224.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $245.6M $245.6M $97.68M
YoY Change
Total Liabilities & Shareholders Equity $311.8M $311.8M $133.9M
YoY Change 132.9% 132.9%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $12.60M -$9.556M $12.13M
YoY Change 3.88% -119.2%
Depreciation, Depletion And Amortization $403.0K $1.400M
YoY Change 55.56%
Cash From Operating Activities $13.93M $66.44M
YoY Change 205.49%
INVESTING ACTIVITIES
Capital Expenditures -$704.0K -$2.712M
YoY Change 19.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$704.0K -$2.712M
YoY Change 19.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 247.0K 75.57M
YoY Change 25604.76%
NET CHANGE
Cash From Operating Activities 13.93M 66.44M
Cash From Investing Activities -704.0K -2.712M
Cash From Financing Activities 247.0K 75.57M
Net Change In Cash 13.48M 139.3M
YoY Change 604.23%
FREE CASH FLOW
Cash From Operating Activities $13.93M $66.44M
Capital Expenditures -$704.0K -$2.712M
Free Cash Flow $14.64M $69.15M
YoY Change 188.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001846576
CY2021 figs Effect Of Dilutive Stock Options And Restrictive Stock Units Per Share
EffectOfDilutiveStockOptionsAndRestrictiveStockUnitsPerShare
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39549
CY2021 dei Entity Registrant Name
EntityRegistrantName
FIGS, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2005653
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
2834 Colorado Avenue
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Monica
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90404
CY2021 dei City Area Code
CityAreaCode
424
CY2021 dei Local Phone Number
LocalPhoneNumber
300-8330
CY2021 dei Security12b Title
Security12bTitle
Class A common stock, $0.0001 par value per share
CY2021Q4 figs Returns Reserve
ReturnsReserve
2761000
CY2020Q4 figs Returns Reserve
ReturnsReserve
1677000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3973000
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
105000
CY2021 dei Trading Symbol
TradingSymbol
FIGS
CY2021 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
4484975898
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young
CY2021 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195374000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58133000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
2056000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2441000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5780000
CY2021Q4 us-gaap Inventory Net
InventoryNet
86068000
CY2020Q4 us-gaap Inventory Net
InventoryNet
49735000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7400000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6665000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
293339000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
120313000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7613000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6529000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10239000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
6507000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
560000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
506000
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
18412000
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
13542000
CY2021Q4 us-gaap Assets
Assets
311751000
CY2020Q4 us-gaap Assets
Assets
133855000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14604000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11965000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24677000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6682000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6464000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4214000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3728000
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3076000
CY2021Q4 figs Gift Card Liability
GiftCardLiability
5590000
CY2020Q4 figs Gift Card Liability
GiftCardLiability
3019000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
207000000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
596000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1781000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154444851
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154444851
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
0
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
62393000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
32519000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3542000
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3659000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
243000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0
CY2021Q4 us-gaap Liabilities
Liabilities
66178000
CY2020Q4 us-gaap Liabilities
Liabilities
36178000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
227626000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
70175000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
17931000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
27487000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
245573000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
97677000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311751000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133855000
CY2021 us-gaap Revenues
Revenues
419591000
CY2020 us-gaap Revenues
Revenues
263112000
CY2019 us-gaap Revenues
Revenues
110494000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
118370000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
72888000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
31158000
CY2021 us-gaap Gross Profit
GrossProfit
301221000
CY2020 us-gaap Gross Profit
GrossProfit
190224000
CY2019 us-gaap Gross Profit
GrossProfit
79336000
CY2021 us-gaap Selling Expense
SellingExpense
81923000
CY2020 us-gaap Selling Expense
SellingExpense
51896000
CY2019 us-gaap Selling Expense
SellingExpense
24840000
CY2021 us-gaap Marketing Expense
MarketingExpense
58713000
CY2020 us-gaap Marketing Expense
MarketingExpense
38852000
CY2019 us-gaap Marketing Expense
MarketingExpense
33193000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
149602000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41536000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21650000
CY2021 us-gaap Operating Expenses
OperatingExpenses
290238000
CY2020 us-gaap Operating Expenses
OperatingExpenses
132284000
CY2019 us-gaap Operating Expenses
OperatingExpenses
79683000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
10983000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
57940000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-347000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-239000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
136000
CY2019 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
460000
CY2021 us-gaap Other Expenses
OtherExpenses
885000
CY2020 us-gaap Other Expenses
OtherExpenses
0
CY2019 us-gaap Other Expenses
OtherExpenses
1000
CY2021 figs Other Income Loss Net
OtherIncomeLossNet
-1124000
CY2020 figs Other Income Loss Net
OtherIncomeLossNet
136000
CY2019 figs Other Income Loss Net
OtherIncomeLossNet
459000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9859000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
58076000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
112000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19415000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8318000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9556000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
49758000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
112000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159177713
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153327308
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153052983
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159177713
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163331348
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153624013
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
24523000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
179000
CY2019 figs Capital Contribution
CapitalContribution
14000000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
112000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
38814000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8713000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-392000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
49758000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
97677000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
95101000
CY2021 figs Restricted Stock Surrendered For Employees Tax Liability
RestrictedStockSurrenderedForEmployeesTaxLiability
-21556000
CY2021 figs Capital Contribution
CapitalContribution
1301000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81139000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-907000
CY2021 figs Tax Benefit Of Deductible Ipo Transaction Costs
TaxBenefitOfDeductibleIpoTransactionCosts
560000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9556000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
245573000
CY2021 us-gaap Profit Loss
ProfitLoss
-9556000
CY2020 us-gaap Profit Loss
ProfitLoss
49758000
CY2019 us-gaap Profit Loss
ProfitLoss
112000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1424000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
946000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
517000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3732000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6507000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-120000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
81139000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
8713000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
179000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3339000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4023000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1266000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36333000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
35435000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
763000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
735000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4672000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-254000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-127000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-38000
CY2019 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
342000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2855000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1207000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2715000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
17983000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4266000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
464000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1185000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
794000
CY2021 figs Increase Decrease In Deferred Rent And Lease Incentive
IncreaseDecreaseInDeferredRentAndLeaseIncentive
-117000
CY2020 figs Increase Decrease In Deferred Rent And Lease Incentive
IncreaseDecreaseInDeferredRentAndLeaseIncentive
734000
CY2019 figs Increase Decrease In Deferred Rent And Lease Incentive
IncreaseDecreaseInDeferredRentAndLeaseIncentive
2915000
CY2021 figs Other Non Current Liabilities To
OtherNonCurrentLiabilitiesTo
-243000
CY2020 figs Other Non Current Liabilities To
OtherNonCurrentLiabilitiesTo
0
CY2019 figs Other Non Current Liabilities To
OtherNonCurrentLiabilitiesTo
0
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
66437000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21748000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6531000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2712000
CY2019 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-712000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2250000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2366000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
713000
CY2021 figs Increase Decrease In Returns Reserve
IncreaseDecreaseInReturnsReserve
1084000
CY2020 figs Increase Decrease In Returns Reserve
IncreaseDecreaseInReturnsReserve
901000
CY2019 figs Increase Decrease In Returns Reserve
IncreaseDecreaseInReturnsReserve
267000
CY2021 figs Increase Decrease In Sales Tax Payable
IncreaseDecreaseInSalesTaxPayable
652000
CY2020 figs Increase Decrease In Sales Tax Payable
IncreaseDecreaseInSalesTaxPayable
527000
CY2019 figs Increase Decrease In Sales Tax Payable
IncreaseDecreaseInSalesTaxPayable
636000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
4428000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
105000
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
CY2021 figs Increase Decrease In Gifts Cards Liability
IncreaseDecreaseInGiftsCardsLiability
2571000
CY2020 figs Increase Decrease In Gifts Cards Liability
IncreaseDecreaseInGiftsCardsLiability
2028000
CY2019 figs Increase Decrease In Gifts Cards Liability
IncreaseDecreaseInGiftsCardsLiability
722000
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2262000
CY2019 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
4761000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2712000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2262000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4761000
CY2021 figs Proceeds From Issuance Of Common Stock For Public Offering Net Of Underwriting Discounts
ProceedsFromIssuanceOfCommonStockForPublicOfferingNetOfUnderwritingDiscounts
95881000
CY2020 figs Proceeds From Issuance Of Common Stock For Public Offering Net Of Underwriting Discounts
ProceedsFromIssuanceOfCommonStockForPublicOfferingNetOfUnderwritingDiscounts
0
CY2019 figs Proceeds From Issuance Of Common Stock For Public Offering Net Of Underwriting Discounts
ProceedsFromIssuanceOfCommonStockForPublicOfferingNetOfUnderwritingDiscounts
0
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
-780000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
181000
CY2020 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
98000
CY2019 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2021 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1301000
CY2020 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2019 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
14000000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
907000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
392000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
21556000
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
75572000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
294000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14000000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
139297000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19780000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15770000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58133000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38353000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22583000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
197430000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58133000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38353000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
15004000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18162000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0
CY2019 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
32000
CY2020 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
236000
CY2019 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
770000
CY2021 figs Deferred Offering Costs In Stockholders Equity Upon Initial Public Offering
DeferredOfferingCostsInStockholdersEquityUponInitialPublicOffering
220000
CY2020 figs Deferred Offering Costs In Stockholders Equity Upon Initial Public Offering
DeferredOfferingCostsInStockholdersEquityUponInitialPublicOffering
0
CY2019 figs Deferred Offering Costs In Stockholders Equity Upon Initial Public Offering
DeferredOfferingCostsInStockholdersEquityUponInitialPublicOffering
0
CY2021Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On May 19, 2021, the Company effected a nine-for-one forward stock split of its issued and outstanding common stock, stock options and RSUs.
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
9
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods presented. Significant estimates include, but are not limited to, the valuation of the net realizable value of inventory, reserves for sales returns, allowances for doubtful accounts, stock-based compensation, contingent sales tax liability, and the useful lives and recoverability of long-lived assets. Actual results could differ from those estimates.</span></p>
CY2021Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
0
CY2020Q4 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentrations of Credit Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company’s cash and cash equivalents are held with creditworthy financial institutions. Although the Company’s deposits held with banks may exceed the amount of federal insurance provided on such deposits, the Company has not experienced any losses in such accounts. The Company invests its excess cash in money market accounts.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash and cash equivalents for the amounts reflected on the balance sheets.</span></p>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
141100000
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
50200000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195374000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58133000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
2056000
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
0
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
197430000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
58133000
CY2021Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
400000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
800000
CY2020Q4 figs Returns Reserve
ReturnsReserve
1700000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
81100000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
419591000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
263112000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110494000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
419591000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
263112000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110494000
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
8700000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
200000
CY2021Q4 figs Returns Reserve
ReturnsReserve
2800000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Expected Dividend
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
0
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
200000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
141104000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
50219000
CY2021Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2441000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5780000
CY2021Q4 figs Prepaid Inventory Deposits Current
PrepaidInventoryDepositsCurrent
798000
CY2020Q4 figs Prepaid Inventory Deposits Current
PrepaidInventoryDepositsCurrent
963000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5440000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1406000
CY2021Q4 figs Estimate Of Contingent Sales Tax Payable
EstimateOfContingentSalesTaxPayable
1600000
CY2020Q4 figs Estimate Of Contingent Sales Tax Payable
EstimateOfContingentSalesTaxPayable
1900000
CY2021 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
The Company leases its office facilities and certain office equipment under non-cancelable operating leases that expire on various dates through December 2029.
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1800000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1900000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
0
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
3493000
CY2021Q4 figs Other Prepaid Expenses And Current Assets
OtherPrepaidExpensesAndCurrentAssets
1162000
CY2020Q4 figs Other Prepaid Expenses And Current Assets
OtherPrepaidExpensesAndCurrentAssets
803000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7400000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6665000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10476000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7968000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2863000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1439000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7613000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6529000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1400000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
500000
CY2021Q4 figs Accrued Inventory
AccruedInventory
16243000
CY2020Q4 figs Accrued Inventory
AccruedInventory
3151000
CY2021Q4 figs Accrued Shipping
AccruedShipping
1077000
CY2020Q4 figs Accrued Shipping
AccruedShipping
656000
CY2021Q4 figs Accrued Selling Expenses
AccruedSellingExpenses
2073000
CY2020Q4 figs Accrued Selling Expenses
AccruedSellingExpenses
1394000
CY2021Q4 figs Accrued Legal Expenses
AccruedLegalExpenses
588000
CY2020Q4 figs Accrued Legal Expenses
AccruedLegalExpenses
986000
CY2021Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
673000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
102000
CY2021Q4 figs Credit Card Liabilities
CreditCardLiabilities
3160000
CY2020Q4 figs Credit Card Liabilities
CreditCardLiabilities
276000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
863000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
117000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24677000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6682000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1963000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
2023000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
2093000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2166000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
2242000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
7206000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17693000
CY2021Q4 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
42000000.0
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
17790000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9087000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5357000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5738000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
23147000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14825000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3014000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3504000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-718000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3003000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3732000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6507000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19415000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8318000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
2083000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
12196000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
23000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
606000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4176000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-344000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
2116000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
0
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-28727000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
0
CY2021 figs Effective Income Tax Rate Reconciliation Excess Compensation Limitations
EffectiveIncomeTaxRateReconciliationExcessCompensationLimitations
45359000
CY2020 figs Effective Income Tax Rate Reconciliation Excess Compensation Limitations
EffectiveIncomeTaxRateReconciliationExcessCompensationLimitations
0
CY2019 figs Effective Income Tax Rate Reconciliation Excess Compensation Limitations
EffectiveIncomeTaxRateReconciliationExcessCompensationLimitations
0
CY2021 figs Income Tax Reconciliation Foreign Derived Intangible Income Deduction
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeduction
-455000
CY2020 figs Income Tax Reconciliation Foreign Derived Intangible Income Deduction
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeduction
0
CY2019 figs Income Tax Reconciliation Foreign Derived Intangible Income Deduction
IncomeTaxReconciliationForeignDerivedIntangibleIncomeDeduction
0
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
230000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
0
CY2021 figs Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
280000
CY2020 figs Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
0
CY2019 figs Income Tax Reconciliation Unrecognized Tax Benefits
IncomeTaxReconciliationUnrecognizedTaxBenefits
0
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
0
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5994000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
75000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
155000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
56000
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
52000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19415000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8318000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.969
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
564000
CY2021Q4 figs Deferred Tax Assets Returns Reserve
DeferredTaxAssetsReturnsReserve
731000
CY2020Q4 figs Deferred Tax Assets Returns Reserve
DeferredTaxAssetsReturnsReserve
469000
CY2021Q4 figs Deferred Tax Assets Tenant Improvement Allowance
DeferredTaxAssetsTenantImprovementAllowance
386000
CY2020Q4 figs Deferred Tax Assets Tenant Improvement Allowance
DeferredTaxAssetsTenantImprovementAllowance
459000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
1063000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
991000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
552000
CY2021Q4 figs Deferred Tax Assets Sales Tax Accrual
DeferredTaxAssetsSalesTaxAccrual
437000
CY2020Q4 figs Deferred Tax Assets Sales Tax Accrual
DeferredTaxAssetsSalesTaxAccrual
528000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
417000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
148000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11984000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8319000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.143
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1217000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1490000
CY2021Q4 figs Deferred Tax Assets Uniform Capitalization Adjustments To Inventory
DeferredTaxAssetsUniformCapitalizationAdjustmentsToInventory
2808000
CY2020Q4 figs Deferred Tax Assets Uniform Capitalization Adjustments To Inventory
DeferredTaxAssetsUniformCapitalizationAdjustmentsToInventory
1135000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3032000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1503000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1341000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1032000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
11984000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
8319000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1745000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1812000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1745000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1812000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
10239000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6507000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
200000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0
CY2021 figs Unrecognized Tax Benefits Settlement With Taxing Authorities
UnrecognizedTaxBenefitsSettlementWithTaxingAuthorities
0
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
167000
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
66000000.0
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y3M18D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
32800000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
50000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
0
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
117000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0115
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0042
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0181
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.48
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.44
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.57
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y5M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39837195
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.49
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y10M13D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
101000000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3843666
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
19.94
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3346352
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.90
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2462829
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.82
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
37871680
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.24
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
846000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
24466168
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.44
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
49800000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
4800000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
200000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M10D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
590000000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
115100000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1200000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.02
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.53
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.25
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-9556000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
49758000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
112000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
159177713
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153327308
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
153052983
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159177713
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
163331348
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
153624013
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2020 figs Effect Of Dilutive Stock Options And Restrictive Stock Units Per Share
EffectOfDilutiveStockOptionsAndRestrictiveStockUnitsPerShare
-0.02
CY2019 figs Effect Of Dilutive Stock Options And Restrictive Stock Units Per Share
EffectOfDilutiveStockOptionsAndRestrictiveStockUnitsPerShare
0
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0

Files In Submission

Name View Source Status
0000950170-22-003380-index-headers.html Edgar Link pending
0000950170-22-003380-index.html Edgar Link pending
0000950170-22-003380.txt Edgar Link pending
0000950170-22-003380-xbrl.zip Edgar Link pending
figs-20211231.htm Edgar Link pending
figs-20211231.xsd Edgar Link pending
figs-20211231_cal.xml Edgar Link unprocessable
figs-20211231_def.xml Edgar Link unprocessable
figs-20211231_htm.xml Edgar Link completed
figs-20211231_lab.xml Edgar Link unprocessable
figs-20211231_pre.xml Edgar Link unprocessable
figs-ex10_10.htm Edgar Link pending
figs-ex10_15.htm Edgar Link pending
figs-ex21_1.htm Edgar Link pending
figs-ex23_1.htm Edgar Link pending
figs-ex31_1.htm Edgar Link pending
figs-ex31_2.htm Edgar Link pending
figs-ex31_3.htm Edgar Link pending
figs-ex32_1.htm Edgar Link pending
figs-ex32_2.htm Edgar Link pending
figs-ex32_3.htm Edgar Link pending
figs-ex4_3.htm Edgar Link pending
figs-ex99_1.htm Edgar Link pending
figs-ex99_1s1.jpg Edgar Link pending
figs-ex99_1s2.jpg Edgar Link pending
figs-ex99_1s3.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img238069633_0.jpg Edgar Link pending
img242687238_0.jpg Edgar Link pending
img39608794_0.jpg Edgar Link pending
img39608794_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending